Potential role of α-synuclein in neurodegeneration: studies in a rat animal model.
Neuronal protein α-synuclein (α-syn) is an essential player in the development of neurodegenerative diseases called synucleinopathies. A spontaneous autosomal recessive rat model for neurodegeneration was developed in our laboratory. These rats demonstrate progressive increases in α-syn in the brain mesencephalon followed by loss of dopaminergic terminals in the basal ganglia (BG) and motor impairments. The severity of pathology is directly related to the overexpression of α-syn and parallel decrease in dopamine (DA) level in the striatum (ST) of affected rats. The neurodegeneration in this model is characterized by the presence of perikarya and neurites Lewis bodies (LB) and diffuse marked accumulation of perikaryal α-syn in the substantia nigra (SN), brain stem (BS), and striatum (ST) along with neuronal loss. Light and ultrastructural analyses revealed that the process of neuronal degeneration is a 'dying back' type. The disease process is accompanied by gliosis and release of inflammatory cytokines. This neurodegeneration is a multisystemic disease and implicate α-syn as a major factor in the pathogenesis of this inherited autosomal recessive animal model. Decrease dopamine (DA) and overexpression of α-syn in the brain mesencephalon may provide a naturally occurring animal model for Parkinson's disease (PD) and other synucleinopathies that reproduces significant pathological, neurochemical, and behavioral features of the human disease.
Department of Veterinary Pathobiology, Texas A&M University, College Station, TX 77843, USA. gstoica@cvm.tamu.edu
George
G
Stoica
Gina
G
Lungu
Nicole L
NL
Bjorklund
Giulio
G
Taglialatela
Xing
X
Zhang
Veronica
V
Chiu
Herbert H
HH
Hill
James O
JO
Schenk
Ian
I
Murray
D000818:Animals; D001479:Basal Ganglia / Q000378:metabolism / Q000473:pathology; D015153:Blotting, Western; D003342:Corpus Striatum / Q000378:metabolism / Q000473:pathology; D016207:Cytokines / Q000378:metabolism; D004298:Dopamine / Q000097:blood / Q000378:metabolism / Q000502:physiology; D059290:Dopaminergic Neurons / Q000502:physiology; D005260:Female; D005911:Gliosis / Q000473:pathology; D020271:Heredodegenerative Disorders, Nervous System / Q000473:pathology*; D007150:Immunohistochemistry; D008297:Male; D013058:Mass Spectrometry; D008636:Mesencephalon / Q000378:metabolism / Q000473:pathology; D046529:Microscopy, Electron, Transmission; D009434:Neural Pathways / Q000378:metabolism / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013378:Substantia Nigra / Q000378:metabolism / Q000473:pathology; D014446:Tyrosine 3-Monooxygenase / Q000096:biosynthesis; D051844:alpha-Synuclein / Q000502:physiology*
D016207:Cytokines; C497606:Snca protein, rat; D051844:alpha-Synuclein; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine